Pramila Rijal

The paper identifies two broadly neutralizing antibodies against Ebolavirus glycoprotein and shows that one enhances the neutralization breadth and potency of other antibodies.

This paper improves the expression and stability of influenza neuraminidase by grafting antigenic loops from low-expressing variants onto high-expressing scaffolds, resulting in vaccine-effective hybrid proteins.

This paper develops a single-cycle influenza vaccine, CLEARFLU, that induces neutralising antibodies to haemagglutinin and T-cell responses, offering broad and strain-specific protection.